Cargando…

Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients

Proton Pump Inhibitors (PPI) are one of the most prescribed medications in the United States. However, PPIs have been shown to increase the risk of enteric infections. Our study aims to evaluate the correlation between PPI and COVID-19 severity. We performed a retrospective cohort study on patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shupp, Brittney, Mehta, Sagar V., Chirayath, Subin, Patel, Nishit, Aiad, Mina, Sapin, Jared, Stoltzfus, Jill, Schneider, Yecheskel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084256/ https://www.ncbi.nlm.nih.gov/pubmed/35534666 http://dx.doi.org/10.1038/s41598-022-11680-0

Ejemplares similares

Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease
por: Liaquat, Hammad, et al.
Publicado: (2021)

Esophageal Neuroendocrine Carcinoma Presenting After Definitive Chemoradiation of Squamous Cell Carcinoma in the Same Location
por: Prenatt, Zarian, et al.
Publicado: (2023)

Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy
por: Aiad, Mina, et al.
Publicado: (2022)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients
por: Matsuda, Hidetaka, et al.
Publicado: (2020)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Does the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?
por: Aiad, Mina, et al.
Publicado: (2022)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review
por: Abbas, Mohammed K, et al.
Publicado: (2019)

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
por: de Araújo, Lorena Maria Lima, et al.
Publicado: (2021)

Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2016)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients
por: Zeng, Yingsi, et al.
Publicado: (2022)

Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients
por: Zhang, Yujing, et al.
Publicado: (2022)

Measuring Mothers’ Viewpoints of Breast Pump Usage
por: Becker, Genevieve E.
Publicado: (2021)

Protonation of key acidic residues is critical for the K(+)-selectivity of the Na/K pump
por: Yu, Haibo, et al.
Publicado: (2011)

The risks of long-term use of proton pump inhibitors: a critical review
por: Jaynes, Megan, et al.
Publicado: (2018)

Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature
por: Briganti, Silvia Irina, et al.
Publicado: (2021)

The Rolling Stone: Bouveret Syndrome Requiring Open Gastrotomy After Failing Electrohydraulic Lithotripsy
por: Prenatt, Zarian, et al.
Publicado: (2023)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
por: Brett, Stephen
Publicado: (2005)

Effect of Using Personal Protective Equipment during the COVID-19 Pandemic on the Quality Indicators of Screening Colonoscopies
por: Chirayath, Subin, et al.
Publicado: (2021)

Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021)

Proton pump inhibitory therapy: then and now.
por: Schepp, W.
Publicado: (1996)

One way for the gastric proton pump
por: Nissen, Poul
Publicado: (2009)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton pumping accompanies calcification in foraminifera
por: Toyofuku, Takashi, et al.
Publicado: (2017)

Impact of aspirin on bleeding and blood product usage in off‐pump and on‐pump coronary artery bypass graft surgery
por: Little, Christopher, et al.
Publicado: (2022)

High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Liaquat, Hammad, et al.
Publicado: (2020)

THU673 Unusual Metastasis Of Differentiated Thyroid Carcinoma
por: Aiad, Mina, et al.
Publicado: (2023)

The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients
por: Khorvash, Farzin, et al.
Publicado: (2014)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oi6sgqamne7qgct9ndr7igombi